Omega Diagnostics Group PLC | Cash Flow

Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
692.90
739.00
571.90
713.30
7,269.60
Depreciation, Depletion & Amortization
679.90
703.60
631.70
597.80
624.60
Other Funds
344.00
162.70
390.30
493.70
745.70
Funds from Operations
1,716.70
1,605.40
1,594.00
1,839.70
6,224.10
Changes in Working Capital
16.00
337.40
148.20
133.10
5,360.00
Net Operating Cash Flow
1,700.70
1,268.00
1,445.70
1,972.80
864.10
Capital Expenditures
2,359.80
2,095.70
2,039.20
2,660.30
3,279.00
Sale of Fixed Assets & Businesses
32.50
8.40
-
-
-
Net Investing Cash Flow
2,327.30
2,087.30
2,039.20
2,660.30
3,279.00
Issuance/Reduction of Debt, Net
121.20
202.50
142.50
20.70
451.50
Net Financing Cash Flow
3,629.20
202.50
142.50
20.70
3,521.30
Net Change in Cash
2,955.30
1,143.90
669.90
564.90
621.60
Free Cash Flow
1,221.80
566.40
825.10
1,381.40
1,336.20
Deferred Taxes & Investment Tax Credit
-
-
-
34.90
324.90
Change in Capital Stock
3,750.40
-
-
-
3,069.80
Exchange Rate Effect
47.30
122.10
66.10
101.90
0.20

About Omega Diagnostics Group

View Profile
Address
Omega House
Alva Scotland FK12 5DQ
United Kingdom
Employees -
Website http://omegadiagnostics.com
Updated 07/08/2019
Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. It operates through the following segments: Allergy and Autoimmune, Food Intolerance, and Infectious Disease. The Allergy and Autoimmune segment involves in the research, development, production and marketing of in-vitro allergy and autoimmune tests.